We came across a bullish thesis on Pfizer Inc. on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on PFE. Pfizer Inc.’s share was trading at $25.86 as of January 28th. PFE’s trailing and forward P/E were 15.41 and 9.14, respectively according to Yahoo Finance.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. PFE has...
